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Objective: A wide selection of both antero-
grade and retrograde mini-invasive proce-
dures exist for stones’ treatment. The 2016 European
Association of Urology (EAU) guidelines still don’t univocally
define a best option. Our purpose is to give an overview on
some European Stone Centers’ customs and to compare real
life clinical practice with statements of opinion leaders and
Guidelines.
Materials and Methods: In 2015 we performed a survey in 3
step about the spread of retrograde intrarenal surgery
(RIRS) and percutaneous nephrolithotomy (PCNL) tech-
niques among EAU Section of Urolithiasis (EULIS) members.
The 1st and 2nd steps dealt with the definition of EULIS
urologist and department by collecting personal opinions
about the endoscopic techniques. The third step was about
clinical results. This paper presents data from the first two
steps.
Results: Ninety-one people answered. Out of them, 80% are
European and 42% work in Centres fully dedicated to stone
treatment. In particular, 50% of responders perform more
than 80 RIRS/year, 25% more than 80 PCNL/year, 48% more
than 100 extracorporeal shock wave lithotripsy (SWL)/year. 
RIRS is mainly used to treat stones < 2 cm both as primary
treatment and after SWL failure. 73% don’t perform routine
pre-stenting and 66% ordinarily use a ureteral sheath.
Hospital stay for RIRS is 24h for 70% of responders.
Regular PCNL is performed by 87% of the responders,
MiniPCNL by 58%, Ultra-MiniPCNL by 23% and
MicroPCNL by 28%. Pneumatic balloon dilation is the
favourite dilation technique (49%). 37% of responders per-
form PCNL always in the supine position, 21% always in the
prone one. Almost all the responders agree about using Mini,
Ultra-Mini and MicroPCNL for 1-2 cm stones.
Approximately 50% also use MiniPCNL for stones > 2 cm.
Conclusion: our survey confirms the great heterogeneity
existing in stones’ treatment techniques in daily practice.
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INTRODUCTION
Urolithiasis management has changed over the past few
decades due to the development of new mini-invasive
instruments and techniques. The possibility to extract a
stone through aa percutaneous access under fluoroscopic
control was given by Johanson and Fernström in 1976 (1).
Between 1981 and 1984 P. Alken, J.A.E. Wickham and J.
Segura described endoscopic percutaneous nephrolithoto-
my (2-5) and Perez Castro in 1980 proposed and promot-
ed rigid ureterorenoscopy in the stone treatment (6). 
Since then, both the anterograde and retrograde tech-
niques were perfected and miniaturized and nowadays
we have a wide selection of procedures focused to the
treatment of renal stones. In 1998 Mini PCNL was men-
tioned for the first time in order to reduce the invasive-
ness of the percutaneous technique (7); in 2011 Mahesh
Desai performed the first Micro PCNL with a 4.8
Charrier (Ch) all seeing needle (8) and in 2013 Janak
Desai described the Ultra-Mini PCNL (UMP) with a 11-
13 Ch access diameter (9). 
2016 European Association of Urology (EAU) Guidelines con-
template all these techniques but still don’t give a clear
indication in order to choose among the “small sized PCNL”
the right one to treat the patient: in fact smaller instruments
present some limitations in the choice of lithotripsy instru-
ments and in clearing fragments, require a longer operation
time, increase intrarenal pelvic pressure while their main
advantage, “id est” less bleeding complications, needs to be
confirmed. Moreover, 2016 EAU Guidelines address PCNL
as the first line treatment in kidney stones > 2 cm while
they do not univocally define the best treatment for calculi
between 1 and 2 cm, leaving the choice to the physician
(10). Many studies in literature make comparisons among
the different techniques and try to suggest how to act in
different situations but still many differences exist, accord-
ing to single centre’s experiences and protocols, in terms of
surgical indications and intra-technique applications. The
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aim of the study is to give an overview on the uses and
practices in some of the main European Stone Centers and
on their indications for stones’ treatment. Secondary objec-
tive is to compare the real life clinical practice with the
indications and statements reported by opinion leaders and
Guidelines.
MATERIAL AND METHODS
We performed a survey approved by the EAU Section of
Urolithiasis (EULIS) board in Cape Town in December
2014 about the spread of RIRS and regular and small sized
PCNL among physicians who attended Copenhagen
EULIS meeting in 2013. The project was accomplished
through the Survey Monkey online platform with a ques-
tionnaire in English in three steps and took place from
February to May 2015.
An introductory email was sent at the beginning with
description and the aim of the survey and with the Survey
Monkey site linked. Participation was voluntary, without
honorarium.
The first step dealt with the definition of EULIS urologist
and department and the second step aimed to define per-
sonal opinions about RIRS and PCNL. From the data we
disposed of at the end of the first two steps, we tried to
delineate EULIS centres’ uses, practices and profiles in
terms of instruments’ availability and techniques per-
formed for stone treatment. Moreover we collected opin-
ions about efficacy and usefulness of the spreading small
sized PCNL techniques. In the third step responders were
asked to share the clinical results of the last 5 cases of each
technique in study with at least one month follow-up. In
this article we will describe and analyze the data resulting
from the first two steps.
RESULTS
We sent the first and second step questionnaires to 360
people and the percentage of responders was 24% (88
responders). Seventy-eight physicians agreed to receive the
third step questionnaire and the 38% out of them (30
responders) shared their data. 
EULIS Physician and Department
96% of EULIS members are urologists and 80% are
European, Table 1.
47% of responders work in academic clinics, 44% in pub-
lic hospitals and 9% in private ones.
The distribution of the sample by age is fairly even in age
groups from 35 to 65 years old, while a less represented
group of responders (14%, 12 out of 88) is younger than
35. 
43% (38 out of 88) of responders work in a stone centre
dedicating all its activity to stone treatment. 
92% of responders work in Centres owning a laser dedi-
cated to lithotripsy and 75% of them in centres owning an
extracorporeal lithotripter.
Three responders out of 88 (3.41%) do not have any flex-
ible ureterorenoscope in their armamentarium, while 39%
of them have 2 or 3 and 42% have more than 4.
50% of responders work in departments performing more
than 80 RIRS/year while 25% of them in departments per-
forming more than 80 PCNL/year, the most represented
group (42%) performing 20-60 PCNL/year. 30% of the
sample work in Departments performing more than 200
extracorporeal shock wave lithotripsy (SWL)/year and 18%
in departments performing 100-200 SWL/year.
Opinions about endoscopic techniques
RIRS
Indications to RIRS, according to responders’ experience,
are resumed in Table 2.
A double J stent is preoperatively placed in less than 1/3 of
the cases by 73% of the EULIS urologists and 66% use an
ureteral access sheath in more than 2/3 of RIRS. 
42% of responders regularly obtain an informed consent
for PCNL before a RIRS and conversion rate from RIRS to
PCNL is lower than 2% for 68% of responders. 
The average hospital stay for RIRS is 24 h for 70% of
responders, 48 h for 22% and more than 2 days for 8%.
PCNLs
The spread of the different PCNL techniques is summa-
rized in Table 3.
Country Responders, No. (%)
Italy 14 (15,9)
Spain 12 (13,6)
UK 10 (11,4)
Denmark, Germany 8 each (9,2 each)
Greece 4 (4,6)
Japan, Portugal, Turkey 3 each (3,4 each)
Bulgaria, France, India 2 each (2,4 each)
Australia, Austria, China, Dubai, Iraq, Lithuania, 
Morocco, Netherlands, Norway, Pakistan, Qatar, 
Serbia, Sweden, Switzerland, Thailand, Uzbekistan 1 each (1,1 each)
Unknown 1 (1,1)
Table 1. 
Distribution of responders for country of origin.
Options Responders, No. (%)
Stones < 1cm (primary treatment) 39 (45)
Stones < 1 cm (after SWL failure) 64 (74)
Stones 1-2 cm (primary treatment) 55 (64)
Stones 1-2 cm (after SWL failure) 54 (63)
Stones > 2 cm (primary treatment) 14 (16)
Stones > 2 cm (after SWL failure) 8 (9)
Table 2. 
Which are your standard indications for RIRS? (More than 
one option allowed; total of 86 responders to this question).
Techniques Responders, No. (%)
Regular PCNL 75 (87)
Mini PCNL 50 (58)
Ultra-Mini PCNL 20 (23)
Micro PCNL 24 (28)
Table 3. 
Which size of PCNL access do you perform? (More than one
option allowed; total of 86 responders to this question).
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Technique skills
Pneumatic balloon dilation is the favourite dilation tech-
nique for 49% of the surgeons, followed by the Alken pro-
gressive technique (29%), the Amplatz progressive tech-
nique (16%) and the Amplatz one shot technique (6%).
37% of responders always perform PCNL with the patient
in any supine position, while 21% always perform the pro-
cedure with the patient in the prone position. 
36% of responders also treat children by PCNL in their
department.
Small size PCNLs
58% of the interviewed urologists perform small sized
PCNL (< 20ch), 88% of the others would be interested in,
but they do not have the equipment. This interest is
stronger regarding UMP than Micro PCNL (respectively
75% and 61% of the respondents who don’t perform these
techniques would be interested in).
The 79% of the responders believe it’s important, in terms
of invasiveness, to move from Regular to Mini PCNL, 54%
from Mini PCNL to UMP and 45% from UMP to Micro
PCNL. Indications to small sized PCNLs and opinions
about their relation with RIRS are resumed in Tables 4 and
5 respectively.
The responders’ favourite stone-breaking energy in Mini
PCNL is laser, used by 90% followed by ballistic energy
used by 32%.
The perceptions of advantages and disadvantages of small
sized PCNL techniques compared to Regular PCNL are
summarized in Figure 1.
DISCUSSION
This paper presents the first Survey inside EULIS group.
Although EULIS is a European Society, 19,1% of respon-
ders come from extra-European countries (Table 1) con-
firming the interest for the European scientific associations.
RIRS
Considering the Departments’ armamentarium almost all
the Centres own a laser dedicated to stone treatment and
more than one flexible ureteroscope, demonstrating the
actual large spread of the retrograde technique. RIRS diffu-
sion is confirmed by the high proportions of centres per-
forming more than 80 procedures per year (50%) that dou-
bles the one of the centres performing the same number of
PCNLs. Anyway SWL appears to be the most popular tech-
nique for stone treatment: in almost 50% of the centres
more than 100 shock-wave treatments per year are per-
formed. It probably suggests that the most of the Stone
Experts use SWL as first approach for stones and this
hypothesis is confirmed by the large proportions of respon-
ders considering SWL as primary treatment for stones < 2
cm (Table 2). Less than 20% of the responders consider
RIRS a suitable technique for stones larger than 2 cm
according to EAU Guidelines that consider PCNL the treat-
Mini PCNL, Ultra-Mini PCNL , Micro PCNL, 
Responders No. (%) Responders No. (%) Responders No. (%) 
(84 responders (83 responders (83 responders
to this question) to this question) to this question)
1-2 cm stones 71 (85) 83 (100) 82 (99)
> 2 cm stones 44 (52) 7 (8) 3 (4)
Table 4. 
What are your indications to small sized PCNL techniques?
Mini PCNL, Ultra-Mini PCNL , Micro PCNL, 
Responders No. (%) Responders No. (%) Responders No. (%) 
(84 responders (83 responders (83 responders
to this question) to this question) to this question)
Yes 38 (45) 41 (49) 27 (33)
Table 5. 
Do you consider small sized PCNLs and RIRS alternative?
Figure 1. 
Advantages and
disadvantages of small
sized PCNL techniques:
responders were asked 
to score every proposed
advantage (black bars) 
and disadvantage (dashed
bars) for all the techniques.
Percentages in the
graphics are the
proportions of responders
considering the proposed
item as a real advantage
or disadvantage. 
The perception of
advantages in Mini PCNL
overwhelms the perception
of disadvantages. This
tendency is reduced for
UMP and inverted for 
Micro PCNL, for which
disadvantages are
considered greater 
than advantages.
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ment of choice. Many studies in literature report high stone
free rates with low morbidity in RIRS performed for stones
larger than 2 cm (11-12) but our survey shows that the
majority of EULIS departments don’t apply these state-
ments in the daily clinical practice.
The majority of responders preoperatively place a ureteral
double J stent only in a small amount of cases according to
expert opinions which don’t recommend routine pre-stent-
ing unless necessary in order to insert a ureteral access
sheath, when the force needed to insert the device in a
prior procedure seems unreasonable (13). 
The ureteral access sheath is largely used by the EULIS
urologists performing RIRS, as extensively suggested in lit-
erature (14) in order to reduce intrapelvic pressure. 
Even if a discrete number of Centres routinely obtain an
informed consent for PCNL before a RIRS, the reported
conversion rate from RIRS to PCNL is very low for the
majority of the Departments.
Hospital stay for RIRS is 24 h for the greatest part of the
departments and this datum confirms what pointed out by
De et al (15). In their review and meta-analysis they
observed, in the majority of the studies analysed, a mean
hospital stay for RIRS between 24 h and 48 h and an over-
all shorter length of stay for RIRS than for PCNL.
PCNLs
The great majority of the urologists perform Regular PCNL
while we observed a smaller diffusion of the PCNLs proce-
dures by reducing the percutaneous tract size (Table 3). As
a matter of facts only a few more than 50% of our respon-
ders perform small size PCNLs even if almost all the other
would be interested in, but they do not have the equip-
ment. This interest appears stronger regarding Mini PCNL
than UMP and Micro PCNL, for which the importance in
terms of invasiveness is considered progressively lower by
reducing the percutaneous access diameter. 
About intraoperative technical manoeuvres, in contrast to
the tendency of EULIS people, who apparently do not
appreciate the Amplatz one shot dilation technique, the
meta-analysis published by Dehong et al. (16) shows that
the one shot technique is safe and effective in all the
patients. According to the same study the balloon dilation,
the preferred technique among EULIS group, is safer and
more effective than the Amplatz progressive dilation and
the Alken’s metal telescopic dilation in patients without
previous open renal surgery, while the effectiveness and
safety of balloon dilation are lower than the Amplatz pro-
gressive and the metal telescopic dilation ones in patients
with densely scarred tissue. 
Yamaguchi et al, in their study on 5537 patients conducted
of behalf of the Clinical Research Office of the Endourological
Society (CROES), report a significantly higher bleeding rate
in patients undergoing balloon dilation compared with tel-
escopic/serial dilation (9.4% vs 6.7%; P < 0.0001). Balloon
dilation was also associated with significantly more trans-
fusions (P = 0.001) and greater drops in haematocrit level
(P < 0.0001) than telescopic/serial dilation, as well as sig-
nificantly longer median operating times (P < 0.0001) (17).
Regarding patient’s position during PCNL, EULIS physi-
cians’ opinions are split, someone always performing the
procedure with the patient in the prone position, some-
one always with the patient in the supine one and some-
one alternating. Liu et al. review and meta-analysis (18)
shows that PCNL in the supine position is as safe and
efficacious as the conventional prone position and there’s
not an overwhelming evidence indicating which one is
better. As concluded by Baard et al., considering the
advantages of supine position in the morbidly obese,
patients with skeletal deformities and patients with
severe cardiorespiratory morbidity, it is important to
have experience with several positions. The decision on
position should be made on patient’s characteristics and
surgeon’s preference and experience (19).
We found in the literature only few articles defining precise
indications to the different percutaneous techniques
according to stone size. In their first paper on UMP, J. Desai
and R. Solanki conclude that their technique is safe and
effective for stones up to 2 cm (9). Ganpule et al., in their
study on factors predicting outcomes of Micro PCNL,
assert that this technique appears to be a promising treat-
ment method for solitary renal stones with volumes < 1000
mm3 and with low density (Hounsfield Units), regardless of
stone location (20). Our responders agree about treating 1-
2 cm stones with Mini, Ultra-Mini and Micro PCNL.
Approximately the half of them also use Mini PCNL for
stones larger than 2 cm, while only a very small proportion
of urologists consider Ultra-Mini and Micro PCNL suitable
techniques for this type of stones.
De et al. review (15) reports that RIRS can provide higher
stone free rates with equal complication rate when com-
pared with minimally invasive percutaneous procedures,
including Mini and Micro PCNL. Nevertheless, almost the
half of our responders consider Mini and Ultra-Mini PCNL
alternative to RIRS in stones treatment, while only a small-
er proportion of urologists thinks the same regarding Micro
PCNL which is probably mainly used in highly selected
cases.
For what concerns responders’ perception of small size
PCNL’s advantages and disadvantages summarized in
Figure 1, Mini PCNL appears to be EULIS urologists’
favourite technique among small size PCNLs.
CONCLUSIONS
Our Survey confirms the great heterogeneity existing in the
treatment of urolithiasis both in the choice of the different
endoscopic techniques and in the surgical steps of the pro-
cedures. Moreover the real-life clinical practice is not
always in line with the literature. 
In particular, while RIRS technique seems to be quite well
standardized, the debate appears to be open on PCNL tech-
niques, in particular regarding the indications to the differ-
ent access tract sizes. The impression is that Micro and
Ultra-Mini PCNL are considered suitable techniques for
stones up to 2 cm, while Mini PCNL could be used in larg-
er stones too, but to assess evidence based indications fur-
ther randomized prospective studies should be performed. 
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